These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7232904)

  • 61. Animal model of depression: effect of nicotergoline and metergoline.
    Golda V; Petr R
    Act Nerv Super (Praha); 1987 Jun; 29(2):115-7. PubMed ID: 3661096
    [No Abstract]   [Full Text] [Related]  

  • 62. [Psychopathometric double blind study with nicergoline versus placebo in geriatric patients with slight transit syndromes].
    Blaha L; Burkard G; Lehrl S; Kapinas K
    Arzneimittelforschung; 1979; 29(8a):1295-301. PubMed ID: 395955
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Effect of nicergoline and dihydroergotamine, injected into the cerebral ventricles, on arterial pressure in the cat].
    Samardzić R; Beleslin D
    C R Seances Soc Biol Fil; 1982; 176(4):488-93. PubMed ID: 6217868
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Current treatment of cerebrovascular disorder with vasoactive drugs].
    Lebiediewa NW
    Neurol Neurochir Pol; 1981; 15(4):417-21. PubMed ID: 6895779
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Study of 2 antianoxic agents by a method of decreased barometric pressure: demonstration of a different rate of action].
    Truchaud M
    Ann Pharm Fr; 1983; 41(4):321-6. PubMed ID: 6670816
    [No Abstract]   [Full Text] [Related]  

  • 66. [Effects of nicergoline on left ventricular function indexes. Comparative study in normotensive and hypertensive patients].
    Monassier JP; Coulbois PM; Weiss JB; Touhami L; Schaaf R; Jehl L; Klenklen F; Monassier C
    Ann Cardiol Angeiol (Paris); 1982; 31(2):155-60. PubMed ID: 7103399
    [No Abstract]   [Full Text] [Related]  

  • 67. Clinical and biochemical effects of nicergoline in chronic schizophrenic patients.
    Albus M; Botschev C; Müller-Spahn F; Naber D; Münch U; Ackenheil M
    Pharmacopsychiatry; 1986 May; 19(3):101-5. PubMed ID: 3725889
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Contingent negative variation and reaction time in patients with presenile idiopathic cognitive decline and presenile Alzheimer-type dementia. Preliminary report on long-term nicergoline treatment.
    Zappoli R; Arnetoli G; Paganini M; Versari A; Battaglia A; Grignani A; Sacchetti G
    Neuropsychobiology; 1987; 18(3):149-54. PubMed ID: 3453431
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Afterload reduction in the critically ill: nicergoline versus sodium nitroprusside.
    Vincent JL; Sarot J; Unger P; Kahn RJ
    J Cardiovasc Pharmacol; 1987 May; 9(5):546-50. PubMed ID: 2439835
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Correction of the alphamimetic effects of metaraminol by nicergoline].
    Maestracci P; Grimaud D; Livrelli N; Griffon H
    Ann Anesthesiol Fr; 1976; 17(11):1255-9. PubMed ID: 15481
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Action of nicergoline on electroencephalographic recovery after cat brain ischemia.
    Suchowsky GK; Pegrassi L
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 284(4):311-8. PubMed ID: 4281059
    [No Abstract]   [Full Text] [Related]  

  • 72. [Buflomedil and nicergoline in the targeted treatment of acute cerebral ischemia. Randomized comparative double blind study].
    Bossi L
    Minerva Med; 1985 May; 76(21):1005-18. PubMed ID: 3889723
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Nicergoline (Sermion). Its use in preparation for anesthesia of aged patients with vascular diseases].
    Mazzarella B; Mastronardi P; Macarone Palmieri A
    Minerva Anestesiol; 1979 Apr; 45(4):223-6. PubMed ID: 551338
    [No Abstract]   [Full Text] [Related]  

  • 74. [Therapy of multi-infarct dementia with nicergoline: double-blind, clinical, psychometric and EEG imaging studies with 2 dosage schedules].
    Saletu B; Hochmayer I; Grünberger J; Böhmer F; Paroubek J; Wicke L; Neuhold A
    Wien Med Wochenschr; 1987 Nov; 137(22):513-24. PubMed ID: 3324497
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Physiopathology of the inner ear and therapy of presbyacusis (author's transl)].
    Aliprandi G; Tantalo V
    Arzneimittelforschung; 1979; 29(8a):1287-95. PubMed ID: 540074
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sustained ventricular unloading action of the alpha-adrenergic antagonist nicergoline in the dog.
    Payen DM; Blanloeil YA; Pinaud ML; Lucas B
    Crit Care Med; 1985 Aug; 13(8):656-60. PubMed ID: 3893889
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Nicergoline and cerebral performance insufficiency. Observations in 1 year treatment controls].
    Kugler J; Heidrich H
    Fortschr Med; 1984 Nov; 102(42):1091-6. PubMed ID: 6392047
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Hemodynamic study of nicergoline].
    Pony JC; Bourdonnec C; Amelot J; Dallerac J; Daubert JC; Gouffault J
    Ann Cardiol Angeiol (Paris); 1982; 31(1):67-70. PubMed ID: 7065627
    [No Abstract]   [Full Text] [Related]  

  • 79. [Sermion treatment of middle-aged and elderly patients with initial atherosclerotic encephalopathy].
    Man'kovskiĭ NB; Mints AIa; Bachinskaia NIu; Kochubeĭ NV
    Vrach Delo; 1989 Apr; (4):60-3. PubMed ID: 2756691
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [The effect of pentoxifylline and nicergoline on the systemic and cerebral hemodynamics and on the blood rheological properties in patients with an ischemic stroke and atherosclerotic lesions of the major cerebral arteries].
    Gara II
    Zh Nevrol Psikhiatr Im S S Korsakova; 1993; 93(3):28-32. PubMed ID: 8042384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.